TNP-470与IL-2对肺癌细胞诱导的血管内皮细胞增殖的抑制作用  

Inhibition of TNP-470 and IL-2 on proliferation of vascular endothelial cell induced by pulmonary adenocarcinoma cell

作　　者：吴晓娟[1] 杨向红[2] 孙立民[3] 孟斌[1] 王志富[1] 

机构地区：[1]山东大学医学院病理教研室,山东济南250012 [2]中国医科大学基础医学院实验病理研究室,辽宁沈阳110001 [3]淄博市临淄区人民医院骨科,山东淄博255000

出　　处：《山东大学学报（医学版）》2005年第12期1140-1143,1147,共5页Journal of Shandong University:Health Sciences

摘　　要：目的:应用体外细胞培养法,探讨TNP-470对肺癌细胞诱导的血管内皮细胞增殖的影响及其机制,以及TNP-470与IL-2联合用药的效应。方法:用免疫细胞化学方法检测血管内皮细胞PCNA、VEGFR-2/Flk-1、FGFR的表达,采用阳性细胞计数法及图像分析法对结果进行分析;用流式细胞分析仪对血管内皮细胞的细胞周期进行分析。结果:TNP-470以剂量依赖方式抑制肺癌细胞条件培养液或细胞粉碎液诱导的血管内皮细胞PCNA、Flk-1、FGFR的表达(与对照组比较P<0.05)。TNP-470与IL-2均可抑制血管内皮细胞进入S期,但两者联合应用时,其效应与各自单独应用无差异(P>0.05)。结论:TNP-470通过降低内皮细胞表面Flk-1、FGFR的表达,抑制内皮细胞进入S期,使内皮细胞阻滞于G0/G1期途径,发挥其抑制血管内皮细胞增殖的效应;而IL-2则通过对内皮细胞的毒性或诱导凋亡作用而发挥其抑制内皮细胞增殖的效应。Objective： To explone the influence and mechanism that TNP-470 inhibits the proliferation of vascular endotheliums induced by pulmonary adenocarcinoma cells and detect the combinative efficacy of TNP-470 and IL-2 on them. Methods： The expression of PCNA, Flk-1, FGFR of endotheliums were tested by immunocytochemical analysis, and the result was positive cell-count and image-analysis methods. The influence of TNP-470 on cell cycle of endotheliums induced by pulmonary adenocarcinoma cells was analyzed by FACScan flow cytometer. Results： TNP-470 inhibited the expression of PCNA, Flk-1 and FGFR of HUVEC induced by pulmonary adenocarcinoma cells dose-dependently compared with conditional group （P〈0.05）. Both TNP-470 and IL-2 can block HUVEC entering S phase, but the combinative efficacy of them is not stronger than that of it （P〉0.05）. Conclusion： TNP-470 can inhibit the proliferation of endotheliums relatively specially by decreasing the expression of Flk-1 and FGFR, further may inhibit the entrance of S phase by blocking them in the G0/G1 phase to play the anti-tumor efficacy; And IL-2 maybe play this efficacy by cytotoxicity to endothelium.

关 键 词：肺肿瘤 TNP-470 白细胞介素-2 内皮 腺癌 血管生成 

分 类 号：R734.2[医药卫生—肿瘤]